Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Nyctalopin Protein (NYX) (Myc-DYKDDDDK Tag)

This Recombinant Nyctalopin protein is produced in HEK-293 Cells.
Catalog No. ABIN2727840

Quick Overview for Nyctalopin Protein (NYX) (Myc-DYKDDDDK Tag) (ABIN2727840)

Target

See all Nyctalopin (NYX) products
Nyctalopin (NYX)

Protein Type

Recombinant

Origin

Human

Source

HEK-293 Cells

Application

Antibody Production (AbP), Standard (STD)

Purity

> 80 % as determined by SDS-PAGE and Coomassie blue staining
  • Purification tag / Conjugate

    This Nyctalopin protein is labelled with Myc-DYKDDDDK Tag.

    Characteristics

    • Recombinant human Nyctalopin protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays

    Comment

    The tag is located at the C-terminal.

    Restrictions

    For Research Use only
  • Concentration

    50 μg/mL

    Buffer

    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

    Storage

    -80 °C

    Storage Comment

    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Target

    Nyctalopin (NYX)

    Alternative Name

    Nyctalopin

    Background

    The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB.

    Molecular Weight

    49.5 kDa

    NCBI Accession

    NP_072089
You are here:
Chat with us!